Clinical Trial
Study Details
Enrollment
173
Interventions
Description
Extra blood samples taken for laboratory analysis
Name
Blood sampling
Type
Procedure
Phase
N/A
Status
COMPLETED
Study ID #
NCT03405688
Study Type
Interventional
Summary
Bearers of the sickle cell allele (S) are currently eligible for blood donations in Belgium. As blood donors are not tested for this allele, their heterozygous status is unknown. However, guidelines recommend to transfuse sickle cell patients with blood that is negative for the 'S' hemoglobin. To the investigator's knowledge, no study has been conducted to evaluate the impact of transfusion with blood originating from heterozygous donors on the transfusion performance and the improvement of clinical status of the sickle cell disease patients.
Study Overview
Conditions
Contacts and Locations
Locations
Facility
CHU Brugmann
1020 Brussels
Belgium
GeoPoint
50.85045, 4.34878
Facility
HUDERF
1020 Brussels
Belgium
GeoPoint
50.85045, 4.34878